Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

Metabolically unhealthy adipose tissue is characterized by reductions in mitochondrial size and function

DeStephanis D., Long MR., Williams AG., Santiago M., Tonkin J., Stevens CM.

Animal Study with a reported sample of 44, published in Obesity (Silver Spring) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Obesity (Silver Spring) (2025)
Reported sample size
44
Source database
Europe PMC
PMID
39948771
PMCID
PMC11897863
DOI
10.1002/oby.24221
Citations
2

Abstract (original English)

Objective Adipose function, not mass, underpins metabolic health. Lean and obese nonhuman primates (NHPs) naturally develop metabolic syndrome. Mitochondria-related measures in subcutaneous adipose tissue (SQ AT) and peripheral blood mononuclear cells may elucidate differences that transcend adiposity measures. Methods Obesity statuses ranged from very lean to severely obese ( 50%, n = 44), which were equivalent in healthy or unhealthy NHPs (metabolic syndrome score difference, p Results Unhealthy adipocytes had mitochondria one-half the size of healthy adipocytes (p Conclusions We conclude that targeting mitochondrial fusion processes would be a rational strategy to improve metabolic health, independent of total fat mass.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Leukocytes, MononuclearMitochondriaAdipocytesAnimalsMacaca mulattaObesityEnergy MetabolismFemaleMaleSubcutaneous Fat

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.